On October 25, 2018, Cellect Biotechnology Ltd. convened an Extraordinary General Meeting of Shareholders. At the Extraordinary Meeting, Jonathan Burgin was elected as an external director for a three-year term ending October 24, 2021. Mr. Burgin will additionally serve on the Company's audit committee and compensation committee. Jonathan Burgin, has served as the CFO and COO of Anchiano Therapeutics Ltd. since October 2016, having previously served as CEO from 2012 to 2016, and as CFO from 2011 to 2012.